A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent

Clinical trial NCT00563563 · COMPLETED

Trial details

NCT number: NCT00563563
Sponsor: Orexigen Therapeutics, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nicotine Dependence Overweight Obesity

Start date: 2007-10-01
Primary completion: 2008-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.